Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in RNAi Technology Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


The future of the global RNAi (Ribonucleic Acid Interference) technology market looks promising with opportunities in the drug discovery and development, and therapeutic applications. The global RNAi technology market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are rising genetic and metabolic disorder and increasing applications of RNAi technology in molecular diagnostics.
 
Emerging trends, which have a direct impact on the dynamics of the industry, include advancement in technologies such as small interfering RNA (siRNA) tolerant to nucleases and non-viral vectors, such as cationic liposomes and nanoparticles.  

A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global RNAi technology market report, please download the report brochure.
 
 
 

 
The study includes trends and forecast for the global RNAi technology market by therapeutic area, application, and region as follows:
 
By Therapeutic Area [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Oncology
  • Ocular Disorders
  • Respiratory Disorders
  • Liver Diseases
  • Neuronal Disorders

By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Drug Discovery & Development
  • Therapeutics
  • Others

By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
  • North America
    • United States
    • Canada 
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • The Rest of the World
    • Brazil
 
Some of the RNAi technology companies profiled in this report include Affymetrix, Agilent Technologies, Bio-Rad Laboratories, GE Healthcare, Illumina, Qiagen, Roche, Sigma Aldrich, Fluidigm, and Thermofisher Scientific.
 
Lucintel forecasts that the oncology will remain the largest segment over the forecast period due to increasing prevalence of cancer and new product development in oncology segment such as small interfering RNA tolerant to nucleases and non-viral vectors, such as cationic liposomes and nanoparticles.

North America will remain the largest region over the forecast period due to increasing investment by biotechnology companies for RNAi therapeutic development in the region.





 
Features of the Global RNAi Technology Market
 
  • Market Size Estimates: Global RNAi technology market size estimation in terms of value ($M) shipment.
  • Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
  • Segmentation Analysis: Global RNAi technology market size by various segments, such as therapeutic area and application in terms of value.
  • Regional Analysis: Global RNAi technology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different therapeutic area, application, and region for the global RNAi technology market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global RNAi technology market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.




 
This report answers following key questions
 
Q.1 What are some of the most promising potential, high-growth opportunities for the global RNAi technology market by therapeutic area (oncology, ocular disorders, respiratory disorders, liver diseases, and neuronal disorders), application (drug discovery & development, therapeutics, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global RNAi technology market?
Q.5 What are the business risks and threats to the global RNAi technology market?
Q.6 What are the emerging trends in this RNAi technology market and the reasons behind them?
Q.7 What are some changing demands of customers in this RNAi technology market?
Q.8 What are the new developments in this RNAi technology market? Which companies are leading these developments?
Q.9 Who are the major players in this RNAi technology market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this RNAi technology market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global RNAi technology market?

 


Report Scope



Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates)		 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Therapeutic Area (Oncology, Ocular Disorders, Respiratory Disorders, Liver Diseases, and Neuronal Disorders) and Application (Drug Discovery & Development, Therapeutics, and Others)

Regional Scope

North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost

Table of Contents

1. Executive Summary

2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global RNAi Technology Market Trends and Forecast
3.3: Global RNAi Technology Market by Therapeutic Area
3.3.1: Oncology 
3.3.2: Ocular Disorders
3.3.3: Respiratory Disorders
3.3.4: Liver Diseases
3.3.5: Neuronal Disorders
3.4: Global RNAi Technology Market by Application
3.4.1: Drug Discovery & Development
3.4.2: Therapeutics
3.4.3: Others

4. Market Trends and Forecast Analysis by Region
4.1: Global RNAi Technology Market by Region
4.2: North American RNAi Technology Market
4.2.1: Market by Therapeutic Area: Oncology, Ocular Disorders, Respiratory Disorders, Liver Diseases, and Neuronal Disorders
4.2.2: Market by Application: Drug Discovery & Development, Therapeutics, and Others 
4.2.3: The United States RNAi Technology Market
4.2.4: The Canadian RNAi Technology Market
4.2.5: The Mexican RNAi Technology Market
4.3: European RNAi Technology Market
4.3.1: Market by Therapeutic Area: Oncology, Ocular Disorders, Respiratory Disorders, Liver Diseases, and Neuronal Disorders 
4.3.2: Market by Application: Drug Discovery & Development, Therapeutics, and Others 
4.3.3: The RNAi Technology Market of United Kingdom
4.3.4: The German RNAi Technology Market
4.3.5: The French RNAi Technology Market
4.4: APAC RNAi Technology Market
4.4.1: Market by Therapeutic Area: Oncology, Ocular Disorders, Respiratory Disorders, Liver Diseases, and Neuronal Disorders 
4.4.2: Market by Application: Drug Discovery & Development, Therapeutics, and Others 
4.4.3: The Chinese RNAi Technology Market
4.4.4: The Indian RNAi Technology Market
4.4.5: The Japanese RNAi Technology Market
4.5: ROW RNAi Technology Market
4.5.1: Market by Therapeutic Area: Oncology, Ocular Disorders, Respiratory Disorders, Liver Diseases, and Neuronal Disorders 
4.5.2: Market by Application: Drug Discovery & Development, Therapeutics, and Others 
4.5.3: Brazilian RNAi Technology Market

5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis

6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin

7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global RNAi Technology Market by Therapeutic Area
7.1.2: Growth Opportunities for the Global RNAi Technology Market by Application
7.1.3: Growth Opportunities for the Global RNAi Technology Market by Region
7.2: Emerging Trends in the Global RNAi Technology Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global RNAi Technology Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global RNAi Technology Market
7.3.4: Certification and Licensing

8. Company Profiles of Leading Players
8.1: Affymetrix Inc.
8.2: Agilent Technologies Inc. 
8.3: Bio-Rad Laboratories Inc.
8.4: GE Healthcare
8.5: Illumina Inc. 
8.6: Qiagen N.V. 
8.7: F. Hoffmann-La Roche Ltd. 
8.8: Sigma Aldrich
8.9: Fluidigm Corporation
8.10: Company 10
 
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: RNAi Technology Market: Trends, Forecast and Competitive Analysis Full Report $ 4,850
150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process. 
 

Please sign in below to get report brochure - RNAi Technology Market.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )
Have an Account / Returning Visitors?

Follow us on